|
p53 - Regulators and Effectors
|
5P01CA080058-09
|
$1,348,536
|
AARONSON, STUART
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
Training Program in Cancer Biology
|
5T32CA078207-10
|
$443,412
|
AARONSON, STUART
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
Studies of Normal and Neoplastic Prostate
|
5U01CA015062-33
|
$215,048
|
AHMED, KHALIL
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Epigenetic markers involved in colorectal cancer recurrence and metastases
|
1K23CA127141-01A1
|
$140,940
|
AHUJA, NITA
|
JOHNS HOPKINS UNIVERSITY
|
|
Functions of EBNA1 in replication & partitioning of EBV
|
5R01CA112564-05
|
$220,812
|
Aiyar, Ashok
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
|
Treatment of Osteoradionecrosis with Bone Marrow Stromal Cells
|
5K08CA120875-03
|
$138,333
|
AKINTOYE, SUNDAY
|
UNIVERSITY OF PENNSYLVANIA
|
|
Neighborhood Characteristics Related to Cancer Risk Factors and Outcomes
|
1R21CA127777-01A1
|
$179,968
|
ALLISON, MATTHEW
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Regulation of Cellular Functions by DNA Tumor Viruses
|
5R01CA028379-28
|
$454,028
|
ALWINE, JAMES
|
UNIVERSITY OF PENNSYLVANIA
|
|
Autophagy inhibition as a therapeutic strategy for glioblastoma mutliforme
|
1R21CA133898-01
|
$369,053
|
AMARAVADI, RAVI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Antioxidant supplements, genetics and chemotherapy outcomes
|
5R01CA116395-03
|
$574,954
|
Ambrosone, Christine
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
NANOTHERAPEUTIC STRATEGY FOR MULTIDRUG RESISTANT TUMORS
|
5R01CA119617-04
|
$362,876
|
AMIJI, MANSOOR
|
NORTHEASTERN UNIVERSITY
|
|
HIV/HPV Cancer Prevention, Treatment & Pathogenesis: Rwanda/Einstein Consortium
|
5U54CA190163-04
|
$701,778
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Mouse Models of Sporadic Colorectal Cancer
|
1K01CA128891-01A1
|
$103,365
|
Angus-Hill, Melinda
|
UNIVERSITY OF UTAH
|
|
Development of Immunotherapeutic Strategies in the Treatment of Lung Cancer
|
1K24CA128953-01A1
|
$161,259
|
ANTONIA, SCOTT
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Mechanisms of PASG-Mediated Senescence in Hematopoietic Development and Leukemia
|
5R01CA120535-02
|
$311,600
|
ARCECI, ROBERT
|
JOHNS HOPKINS UNIVERSITY
|
|
Patient-specific therapy of glioblastoma using lightly-labeled [14C]-temozolomide
|
1R43CA134184-01
|
$102,900
|
Arjomand, Ali
|
ACCIUM BIOSCIENCES, INC.
|
|
Telomeres, telomerase and chemotherapy: Bench to bedside
|
7R01CA077091-05
|
$338,540
|
Au, Jessie
|
OPTIMUM THERAPEUTICS, LLC
|
|
Role of alpha4-paxillin signaling in lymphangiogenesis
|
1F32CA134118-01
|
$46,826
|
Avraamides, Christie
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Novel Biophotonics Methodology for Colon Cancer Screening
|
1R01CA128641-01A1
|
$1,160,563
|
BACKMAN, VADIM
|
NORTHWESTERN UNIVERSITY
|
|
Spousal Support, Emotional Disclosure, and Adjustment to Head and Neck Cancer
|
1K07CA124668-01A2
|
$136,080
|
BADR, HODA
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
MDR Gene Polymorphisms in AML
|
5R21CA127848-02
|
$152,990
|
BAER, MARIA
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Hsp90 as a Target for the Treatment of Childhood Cancer
|
5K23CA107450-03
|
$119,402
|
BAGATELL, ROCHELLE
|
UNIVERSITY OF ARIZONA
|
|
Organized Labor and Tobacco
|
5R01CA095964-06
|
$332,886
|
BALBACH, EDITH
|
TUFTS UNIVERSITY MEDFORD
|
|
Pharmacokinetic strategies to optimize IP chemotherapy
|
5R01CA118213-03
|
$255,609
|
BALTHASAR, JOSEPH
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
|
ErbB2 Downregulation Through HSP90 Inhibition
|
5R01CA116552-03
|
$279,300
|
Band, Hamid
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Mouse Model of Pancreatic Cancer Progression-Maintenance
|
5K01CA104647-04
|
$161,730
|
BARDEESY, NABEEL
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Proton MRSI of Human Breast Cancer at 3 and 7 Tesla
|
5R01CA125258-02
|
$391,061
|
BARKER, PETER
|
JOHNS HOPKINS UNIVERSITY
|
|
Mitochondria Targeted Anti-oxidant for Treatment of Prostate Cancer
|
1R43CA130222-01A1
|
$109,558
|
BASU, HIRAK
|
COLBY PHARMACEUTICAL COMPANY
|
|
Clinical and Molecular Studies of Novel Therapeutics in Malignant Brain Tumors
|
5K24CA125440-02
|
$187,934
|
Batchelor, Tracy
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Tumor-Targeting Oligonucleotides
|
5R01CA122383-03
|
$255,082
|
BATES, PAULA
|
UNIVERSITY OF LOUISVILLE
|
|
Focal Adhesion Kinase (FAK) in Human Neuroblastoma
|
5K08CA118178-02
|
$134,435
|
BEIERLE, ELIZABETH
|
UNIVERSITY OF FLORIDA
|
|
Safety of Nicotine Reduction Strategy
|
5R01CA078603-09
|
$563,228
|
BENOWITZ, NEAL
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Pulmonary rehabilitation before lung cancer resection.
|
7K23CA106544-05
|
$133,650
|
BENZO, ROBERTO
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
RRM1 in the Management of Lung Cancer
|
1R01CA129343-01A1
|
$618,334
|
BEPLER, GEROLD
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Statistical Methods for Analysis of Failure Time Data
|
5R01CA075971-10
|
$238,926
|
Betensky, Rebecca
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
|
Targeting Apoptosis Signaling in Breast Cancer Cells
|
5R01CA099999-06
|
$228,588
|
BHALLA, KAPIL
|
MEDICAL COLLEGE OF GEORGIA (MCG)
|
|
Lupeol, A Novel Fuit and Vegetable Based Triterpene for Prostate Cancer
|
5R03CA130064-02
|
$73,500
|
BHAT, MOHAMMAD
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Resistance of CML Stem Cells to Imatinib (Gleevec)
|
2R01CA095684-05
|
$321,555
|
BHATIA, RAVI
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Engineering Multifunctional Nanoparticles
|
5R01CA124427-03
|
$817,618
|
BHATIA, SANGEETA
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Energy Balance, IGF Dysregulation and Multiple Myeloma
|
5K07CA115687-03
|
$140,130
|
BIRMANN, BRENDA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
The Molecular Analysis of Tumor Viruses
|
5T32CA009043-34
|
$624,449
|
BISHOP, J
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Early Detection of Liver Cancer
|
5U01CA084951-10
|
$424,009
|
BLOCK, TIMOTHY
|
DREXEL UNIVERSITY
|
|
Experimental Therapeutics in Acute Leukemias
|
5K23CA120708-03
|
$129,720
|
BLUM, WILLIAM
|
OHIO STATE UNIVERSITY
|
|
Brain Neoplasia and Multiple Quantum Sodium MRI
|
5R01CA106840-04
|
$278,090
|
BOADA, FERNANDO
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Glioma Therapeutics Targeting Glioma Pathogenesis-related Protein
|
1R43CA123991-01A2
|
$219,461
|
Bonafe, Nathalie
|
L2 DIAGNOSTICS, LLC
|
|
The role of myeloid suppressor cells in tumor-specific tolerance
|
5R01CA124996-02
|
$311,600
|
BORRELLO, IVAN
|
JOHNS HOPKINS UNIVERSITY
|
|
Oncolytic activity of respiratory syncytial virus against prostate cancer
|
1R21CA129246-01A1
|
$166,500
|
BOSE, SANTANU
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
ADJUVANT TRIAL WITH SOY AFTER RADICAL PROSTATECTOMY
|
5R01CA116195-04
|
$321,017
|
BOSLAND, MAARTEN
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
|
5R01CA114456-03
|
$477,102
|
BOSTICK, ROBERD
|
EMORY UNIVERSITY
|
|
Improving Dietary Assessment Methods Using the Cell Phone and Digital Imaging
|
5U01CA130784-02
|
$503,163
|
BOUSHEY, CAROL
|
PURDUE UNIVERSITY WEST LAFAYETTE
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|